(NASDAQ: PETS) Petmed Express's forecast annual revenue growth rate of -5.06% is not forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of -2.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.57%.
Petmed Express's revenue in 2025 is $247,010,000.On average, 1 Wall Street analysts forecast PETS's revenue for 2026 to be $4,466,153,224, with the lowest PETS revenue forecast at $4,466,153,224, and the highest PETS revenue forecast at $4,466,153,224.
In 2027, PETS is forecast to generate $4,599,469,998 in revenue, with the lowest revenue forecast at $4,599,469,998 and the highest revenue forecast at $4,599,469,998.